• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  11/30/2012
Trade Name:  Invirase
Generic Name or Proper Name (*):  saquinavir
Indications Studied:  Treatment of HIV infection in combination with ritonavir
Label Changes Summary:  *The safety and activity of saquinavir have been evaluated in 68 pediatric patients 4 months -< 16 years treated with Invirase boosted with either ritonavir or with lopinavir/ritonavir in 2 clinical trials. * Steady state saquinavir exposures observed in pediatric trials were substantially higher than historical data in adults where dose- and exposure-dependent QTc and PR prolongation were observed. Pediatric dose recommendations that are both reliably effective and below thresholds of concern with respect to QT and PR prolongation could not be determined. * Information on clinical studies, and pharmacokinetics
Product Labeling:  urlLabeling  Opens a new window
BPCA(B) and PREA(P):  B,P
Sponsor:  Hoffman- LaRoche
Pediatric Exclusivity Granted Date:  10/26/2010
NNPS:  False
Therapeutic Category:  Antiviral